These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11407523)

  • 41. Prognostic value of renal cell carcinoma nuclear grading: multivariate analysis of 333 cases.
    Ficarra V; Righetti R; Martignoni G; D'Amico A; Pilloni S; Rubilotta E; Malossini G; Mobilio G
    Urol Int; 2001; 67(2):130-4. PubMed ID: 11490206
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A; Mandhani A; Kapoor R; Jain M; Dubey D; Srivastava A; Raghavendra M; Kumar A
    Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
    Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
    Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The chromophobe tumor grading system is the preferred grading scheme for chromophobe renal cell carcinoma.
    Finley DS; Shuch B; Said JW; Galliano G; Jeffries RA; Afifi AA; Castor B; Magyar C; Sadaat A; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2011 Dec; 186(6):2168-74. PubMed ID: 22014797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases.
    Ficarra V; Righetti R; Pilloni S; D'amico A; Maffei N; Novella G; Zanolla L; Malossini G; Mobilio G
    Eur Urol; 2002 Feb; 41(2):190-8. PubMed ID: 12074408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma.
    Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF
    J Clin Pathol; 1994 Apr; 47(4):324-8. PubMed ID: 8027369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of extensive necrosis in renal cell carcinoma.
    Collins J; Epstein JI
    Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases.
    Amin MB; Crotty TB; Tickoo SK; Farrow GM
    Am J Surg Pathol; 1997 Jan; 21(1):1-12. PubMed ID: 8990136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of tumor volume on survival in patients with renal cell carcinoma.
    Seçil M; Çullu N; Aslan G; Mungan U; Uysal F; Tuna B; Yörükoğlu K
    Diagn Interv Radiol; 2012; 18(5):480-7. PubMed ID: 22618630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic value of Fürhman's grade in renal cell carcinoma. A study of 170 cases].
    Dupré F; Guyétant S; Chautard D; Burtin P; Saint-André JP
    Ann Pathol; 1998 Apr; 18(2):88-97. PubMed ID: 9608860
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal cell carcinoma with rhabdoid features.
    Gökden N; Nappi O; Swanson PE; Pfeifer JD; Vollmer RT; Wick MR; Humphrey PA
    Am J Surg Pathol; 2000 Oct; 24(10):1329-38. PubMed ID: 11023094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear morphometry and stereology in nasopharyngeal carcinoma.
    Reifen E; Noyek AM; Mullen JB
    Laryngoscope; 1992 Jan; 102(1):53-5. PubMed ID: 1731158
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interobserver reproducibility of a grading system for chromophobe renal cell carcinoma.
    Pérez-Pedrosa A; Ortiz-Rey JA; Lorenzo-Mahía Y; Iglesias-Rodríguez B; Peteiro-Cancelo A; González-Carreró J
    Actas Urol Esp; 2013 Jun; 37(6):338-41. PubMed ID: 23058995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphometrically assisted grading of astrocytomas.
    Scarpelli M; Bartels PH; Montironi R; Galluzzi CM; Thompson D
    Anal Quant Cytol Histol; 1994 Oct; 16(5):351-6. PubMed ID: 7840841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleophosmin expression in renal cell carcinoma and oncocytoma.
    Sari A; Calli A; Altinboga AA; Pehlivan FS; Gorgel SN; Balci U; Ermete M; Dincel C; Cakalagaoglu F
    APMIS; 2012 Mar; 120(3):187-94. PubMed ID: 22339675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Value of morphometry as an independent prognostic factor in renal cell carcinoma.
    Ruiz JL; Hernández M; Martínez J; Vera C; Jimenez-Cruz JF
    Eur Urol; 1995; 27(1):54-7. PubMed ID: 7744143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stage I renal cell carcinoma. A clinicopathologic study of 82 cases.
    Gelb AB; Shibuya RB; Weiss LM; Medeiros LJ
    Am J Surg Pathol; 1993 Mar; 17(3):275-86. PubMed ID: 8434708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nuclear planimetry in renal-cell tumors.
    González-Cámpora R; González de Chaves FJ; Mora-Marin J; Rodriguez-González R; Utrilla-Alcolea JC; Rubí-Uría J; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):54-60. PubMed ID: 2025374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.